Loading clinical trials...
Loading clinical trials...
This is the first study of oral tofacitinib in adults with active ankylosing spondylitis. It is designed to obtain information on the efficacy and safety of 3 different doses of tofacitinib.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more
NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT07172360 · Active Ankylosing Spondylitis
NCT07261644 · Ankylosing Spondylitis
Desert Medical Imaging
Indian Wells, California
Desert Medical Advances
Palm Desert, California
Arthritis & Rheumatology Associates
Clearwater, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions